Parâmetros laboratoriais e idade como indicadores de risco de mortalidade no diagnóstico de SARS-CoV-2
PDF (Português (Brasil))

Keywords

Covid-19
Mortalidade
Inflamação
Imunosenescência
Índice de Massa Corporal

How to Cite

Pozzobon, A., Perondi Castoldi, A., Bandeira, J. R., Ribeiro de Castro Cardoso, L., Portaluppi Michelon, C., Resmini Durigon, G., Vedoin Sousa, C., Zago Cembranel, V., Biolchi, V., & Muccillo Dexheimer, G. (2024). Parâmetros laboratoriais e idade como indicadores de risco de mortalidade no diagnóstico de SARS-CoV-2. Brazilian Journal of Implantology and Health Sciences, 6(8), 2187–2204. https://doi.org/10.36557/2674-8169.2024v6n8p2187-2204

Abstract

The present study aimed to evaluate the clinical characteristics of hospitalized patients with signs and symptoms of covid-19 and laboratory tests of these patients, verifying its relationship with mortality. A total of 500 medical records were analyzed of patients diagnosed with covid-19 during the years 2020 and 2021.  The mean total age was 61.27, and the average body mass index was 30.09Kg/m2. In the risk analysis, patients over 72 years old, the risk is 3.74 (222 to 6.29) times greater dying than patients under 72 years. A significant relationship was observed with age, hematological inflammatory markers and coagulation markers. This study shows that obesity alone was not a determinant for the risk of mortality in the evaluated population. Age was a determining factor for this risk. This characteristic can be explained by the mechanism of immunosenescence observed in this population.

https://doi.org/10.36557/2674-8169.2024v6n8p2187-2204
PDF (Português (Brasil))

References

ALEL, QAQA, ABUARQOUB, SHAMOON.Akel T, Qaqa F, Abuarqoub A, Shamoon F. Pulmonary embolism: A complication of COVID 19 infection. Thromb Res. 2020 Sep;193:79-82. doi: 10.1016/j.thromres.2020.05.033. Epub 2020 May 25. PMID: 32526545; PMCID: PMC7247481.

ALLEGRA, Alessandro, et al. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications. International Journal of Molecular Sciences, v. 21, n. 13, p. 4782, 6 jul. 2020. Disponível em: https://www.mdpi.com/1422-0067/21/13/4782/htm.

ALMEIDA J e CHEHTER E. COVID-19 and the gastrointestinal tract: what do we already know? Instituto Israelita de Ensino e Pesquisa Albert Einstein. São Paulo, Brasil; 2020.

BASTOS, Leonardo, et al. COVID-19 e hospitalizações por SRAG no Brasil: uma comparação até a 12ª semana epidemiológica de 2020. Cadernos de Saúde Pública [online]. v. 36, n. 4, Epub. 22 Abr 2020. Disponível em: https://doi.org/10.1590/0102-311X00070120

BATSCHAUER, Anna, et al. Hemostasia e COVID-19: fisiopatologia, exames laboratoriais e terapia anticoagulante. Revista Brasileira de Análises Clínicas [RBAC], v. 52, n. 2, p. 138, Epub. 17 ago. 2020. Disponivel em: https://www.researchgate.net/profile/Liane-Rotta-2/publication/347283532_Insuficiencia_renal_aguda_em_pacientes_com_COVID-19/links/6100bb2b1e95fe241a919d7b/Insuficiencia-renal-aguda-em-pacientes-com-COVID-19.pdf#page=35

BERGAMASCHI, Gaetano, et al. Internal Medicine Covid-19 Collaborators. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med. p. 239-246, Epub. 08 jan. 2021. Disponivel em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790728/pdf/10238_2020_Article_679.pdf

CAVALCANTE-SILVA, Luiz Henrique Agra et al. Neutrophils and COVID-19: The road so far. International immunopharmacology, v. 90, p. 107233, 2021.

Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, Li T, Margolick JB, Pawelec G, Leng SX. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021 Jan;65:101205. doi: 10.1016/j.arr.2020.101205. Epub 2020 Oct 31. PMID: 33137510; PMCID: PMC7604159.

COATES T.D. Approach to the patient with neutrophilia. UpToDate. Disponível em: <https://www.uptodate.com/contents/approach-to-the-patient-with-neutrophilia?search=leuc%C3%B3cito&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2>. Acessado em: 30 jun. 2021

CHEN, Jieliang. Pathogenicity and transmissibility of 2019-nCoV—a quick overview and comparison with other emerging viruses. Microbes and infection, v. 22, n. 2, p. 69-71, 2020.

GOMEZ-MESA, J; GALINDO-CORAL, S; MONTES, MC; MUNOZ, AJ; Thrombosis and Coagulopathy in COVID-19. Curr Probl Cardiol. 2021 Mar;46(3):100742. doi: 10.1016/j.cpcardiol.2020.100742. Epub 2020 Nov 2. PMID: 33243440; PMCID: PMC7605852.

GRASSELLI, Giacomo et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA internal medicine, v. 180, n. 10, p. 1345-1355, 2020.

ISER, B; SILVA, I; RAYMUNDO, V; POLETO, M; SCHUELTER-TREVISOL, F; BOBINSKI, F. Suspected COVID-19 case definition: a narrative review of the most frequent signs and symptoms among confirmed cases. Scielo, 2020. https://doi.org/10.5123/S1679-49742020000300018

JERGOVIĆ, Mladen et al. Immune response to COVID-19 in older adults. The Journal of Heart and Lung Transplantation, v. 40, n. 10, p. 1082-1089, 2021.

LAUER, Stephen A. et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine, v. 172, n. 9, p. 577-582, 2020.

LI, Y; ZHAO, K; WEI, H; CHEN, W; WANG, W; JIA, L; LUI, Q; ZHANG, J; SHAN, T; PENG, Z; LUI, Y; YAN, X. Dynamic relationship between D-dimer and COVID-19 severity. British Journal of Haematology, 2020. https://doi.org/10.1111/bjh.16811.

LIMA, GB., et al. Os valores de referência do D-dímero no contexto da Covid-19: O que sabemos até agora?. Hematology, Transfusion and Cell. v. 44, s. 2, p. 688, Epub. Out. 2022. Disponível em: https://www.sciencedirect.com/science/article/pii/S2531137922012974

LUO S, ZHANG X, XU H. Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19). Clin Gastroenterol Hepatol. 2020;

NASCIMENTO, Jorge, et al. COVID-19 e Estado de Hipercoagulabilidade: Uma Nova Perspectiva Terapêutica. Arquivos Brasileiros de Cardiologia. v. 114, n. 5, pp. 829-833, Epub 01 Jun 2020. Disponível em: https://doi.org/10.36660/abc.20200308.

NERI, BR., et al. Análise da alteração do D-dímero em pacientes com Covid-19. Hematology, Transfusion and Cell. v. 43, s.1, p. 239-240. Epub Out. 2021. Disponível em: https://www.sciencedirect.comscience/article/pii/S2531137921005538?via%3Dihub

PAULA, Henrique, et al. Alterações hematológicas da Covid-19. Revista Brasília Med. v. 58, p.1-6, Epub. 1 ago. 2021. Disponível em: https://cdn.publisher.gn1.link/rbm.org.br/pdf/v58a53.pdf.

PEREIRA, Ana Flávia, et al. Hematological alterations and hemostasis in COVID-19: a literature review. Research, Society and Development, v. 10, n.11, e. 171101119409, 27 ago 2021. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/19409/17400.

SAHU, Bikash R. et al. C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection. Clinica chimica acta, v. 509, p. 91-94, 2020.

TAVARES, Caio, et al. Alterações da ECA2 e Fatores de Risco para Gravidade da COVID-19 em Pacientes com Idade Avançada. Arquivos Brasileiros de Cardiologia [online]. v. 115, n. 4, p. 701-707, Epub. 23 Out 2020. Disponível em: https://doi.org/10.36660/abc.20200487

TEN-CATEN, F. In-depth Analysis of Laboratory Parameters Reveals the Interplay between Sex, Age and Systemic Inflammation in Individuals with COVID-19. MedRxiv, 2020.

VARGAS, Ciro Maguiña, et al. El nuevo Coronavirus y la pandemia del Covid-19. Rev Med Hered, Lima, v. 31, n. 2, pág. 125-131, abr. 2020. Disponível em http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1018-130X2020000200125&lng=es&nrm=iso.

VILLANUEVA M, FAUNDEZ R, GODOY M. Gastrointestinal and hepatic manifestations of COVID-19 in children. Revista Chilena de Pediatria. Santiago, Chile, vol.91 no.4 Santiago ago. 2020.

WANG, Yunan et al. Immunosenescence, aging and successful aging. Frontiers in immunology, v. 13, p. 942796, 2022.

WANG, Jun et al. Excessive neutrophils and neutrophil extracellular traps in COVID-19. Frontiers in immunology, v. 11, p. 2063, 2020.

WIERSINGA, W. Joost et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Jama, v. 324, n. 8, p. 782-793, 2020.

WHO. Global research on coronavirus disease (COVID-19). World Health Organization, mar./2020. Disponível em: https://www. who.int/emergencies/diseases/novel-coronavirus-2019/globalresearch-on-novel-coronavirus-2019-ncov. Acesso em: 10 ago. 2020.

XAVIER, Analucia R., et al. COVID-19: manifestações clínicas e laboratoriais na infecção pelo

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Adriane Pozzobon, Alencar Perondi Castoldi, Jardel Rodrigo Bandeira, Laura Ribeiro de Castro Cardoso, Camila Portaluppi Michelon, Gabriela Resmini Durigon, Caroline Vedoin Sousa, Victória Zago Cembranel, Vanderlei Biolchi, Geórgia Muccillo Dexheimer